Events in March 2012

  • March 1, 2012

    arrow-rightNext Steps for Instructors

    Time: 4:00 PM - 5:00 PM

    Location: E Shapiro 202, 330 Longwood Avenue, Boston, MA, 02115

    The Office of Academic Careers and Faculty Development at Beth Israel Deaconess Medical Center is hosting a series of workshops for post-docs and instructors, led by Dr. Terry Maratos-Flier, that will address the specific factors one must consider for future career development, and the paths forward from the post-doc and instructor experiences. These workshops are open to the Harvard community and affiliated hospitals.

    Workshop 3: Next Steps for Instructors

    This is a workshop to discuss issues regarding promotion at Harvard Medical School versus outside opportunities.

    To register for this workshop, please email the BIDMC Office for Academic Careers and Faculty Development.

    For more information and questions, please email Elizabeth Langley.

  • March 6, 2012

    arrow-rightAddiction Genetics and Bringing a Gun to a Gunfight

    Time: 10:00 AM - 11:00 AM

    Location: Garrod and Mendel Conference Room, Richard B. Simches Building, 185 Cambridge St, Boston, MA 02114

    Speaker: Joel Gelernter, MD, Yale University

    This presentation is hosted by the Psychiatric Genetics and Translational Research Seminar (PGTRS). No preregistration is required. The PGTRS is a weekly seminar sponsored by the Psychiatric Genetics Program in Mood and Anxiety Disorders within the Department of Psychiatry at Massachusetts General Hospital. Devoted to genetic, clinical, and translational research in psychiatry and neuroscience, the seminar series is open to investigators, clinicians, and trainees.

    For more information, please see our website:

  • March 21, 2012

    arrow-rightBiostats Seminar on Capture-Recapture Methods

    Time: 3:00 PM - 5:00 PM

    Location: Audtiorium A, Children’s Hospital Boston, 1 Autumn St, Boston, MA, 02215

    Speakers: Al Ozonoff, PhD, Children’s Hospital Boston; Les Boden, PhD, Boston University School of Public Health

    In this Harvard Catalyst Biostatistics Seminar, speakers will discuss issues related to capture-recapture methods, occupational health surveillance, and population-level research.

    The methodology of capture-recapture (sometimes referred to as mark-and-release or capture-mark-release-recapture) has its earliest roots in demography from an application of Laplace over 300 years ago. The modern treatment of the subject began in the late 19th century with ecological applications, and has extended to applications in human health over the past fifty years.

    In this talk, capture-recapture methods will serve as a jumping-off point to explore the deep historical connections between statistics and public health surveillance.  We will discuss applied methodological research in this context as an example  of translation to population health – T4 on the clinical and translational research spectrum.  

    The seminar will start with a presentation of the history of capture-recapture and its applications to problems in public health, the statistical principles and foundations of the methodology, and then explore questions that may arise during design and implementation of cap-recap studies.  The second half of the seminar will provide a brief introduction to occupational health, in particular its use of cap-recap methods to estimate the population-level burden of workplace injuries, and also offer some practical lessons learned after over 30 years of research in the field.  The conclusion of the seminar will engage the audience in an open discussion focused on how to bring important statistical advances ‘to bedside’, i.e.: making useful and effective tools available to those who will have the greatest impact on problems of public health. A reception will follow the proceedings.

    For more information on the Harvard Catalyst Biostatistics Program, please visit our website.

  • March 28, 2012

    arrow-rightCultural Competence in Research Symposium, Featuring The Bok Players

    Time: 3:00 PM - 5:00 PM

    Location: Jimmy Fund Auditorium, Dana-Farber Cancer Institute, 35 Binney Street,Boston, MA 02115

    Join us for an interactive learning experience exploring the complexities of issues such as how best to engage diverse communities in research, establish trust across cultures, respect the diversity of communities, obtain consent from minority populations, encourage minority accrual in clinical research, and deal with unconscious personal bias and stereotyping.

    This free event will engage participants via the Bok Players – an interactive theatre group serving academia – whose performances will highlight some of the key principles of working with diverse communities in clinical and translational research. Following each performance, the Bok Players will facilitate an interactive discussion and Q&A session. These discussions will be supplemented by a panel of experts in areas such as health disparities, human subject protection/research regulations, and research subject advocacy.

    Presented in partnership by Harvard Catalyst’s Regulatory Knowledge and Support Program, Community Health Innovation and Research Program (CHIRP), The Harvard Catalyst Clinical Research Center (HCCRC), the Survey and Statistical Methods and Training Cores of the University of Massachusetts Boston – Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership to Reduce Cancer Health Disparities, and Dana-Farber/Harvard Cancer Center – Initiative to Eliminate Cancer Disparities.

    The event is free and open to all faculty, staff, and community members.

    Registration will open soon. For more information, contact Elizabeth Witte via e-mail.

  • March 29, 2012

    arrow-rightImaging the Cancer Cell

    Time: 09:00 AM - 1:45 PM

    Location: DFCI Jimmy Fund Auditorium. 35 Binney St, Boston MA 02115

    The DF/HCC Cancer Cell Biology Program is proud to present a new symposium, "Imaging the Cancer Cell."


    This symposium brings together basic scientists and clinicians from across HMS with the goal of accelerating translational applications of basic cell biology research.


    The Keynote Speaker will be John Condeelis, PhD. Dr. Condeelis is Professor & Co-Chair of Anatomy & Structural Biology at the Albert Einstein College of Medicine. He is Co-Director of the Gruss Lipper Biophotonics Center.


    Also speaking:


    Gaudenz Danuser, PhD

    Galit Lahav, PhD

    Charles Lin, PhD

    Tim Mitchison, PhD

    Ralph Weissleder, MD, PhD

    Please register at


  • March 29, 2012

    arrow-rightApplying Ecological and Evolutionary Theory to the Challenge of Antibiotic Resistance

    Time: 6:00 PM - 9:00 PM

    Location: TMEC Walter Amphitheater, 260 Longwood Ave, Boston, MA, 02115

    Keynote Speaker: Margaret (Peg) Riley, Ph.D.
    Professor-University of Massachusetts, Amherst
    Founder and President-Massachusetts Academy of Sciences
    Founder and Co-Director-Institute for Drug Resistance
    Founder and CSO-Origin Antimicrobials, LLC

    The Harvard Catalyst Laboratory for Innovative Translational Technologies (HC-LITT) and the Harvard Catalyst Central Laboratory (HCCL) are hosting a seminar on the issue of microbial drug resistance. Pathogenic bacteria resistant to many or all antibiotics already exist and are growing in number. Coupled with the rapid decline in microbiological research at pharmaceutical companies, the rapid rate at which resistance has evolved and spread has demanded a novel approach to address this critical human health issue.

    The presentation will highlight a new paradigm in antibiotic discovery and development, one that applies ecological and evolutionary theory to design novel antimicrobial drugs, as well as presenting defensive strategies invented and applied by bacteria for the past several billion years and the adoption of these strategies in our fight against microbial drug resistance.

    To register, click here.

    The mission of HC-LITT is to provide the Harvard research community with early access to enabling leading-edge genomic and proteomic technologies. The mission of HCCL is to perform specialty tests in a CLIA-certified central laboratory at low cost and high consistent quality.

    Hosted by the Harvard Catalyst Laboratory for Innovative Translational Technologies (HC-LITT) and the Harvard Catalyst Central Laboratory (HCCL). Harvard University, HC-LITT, HCCL, and Harvard Catalyst do not endorse any company or product. The opinions expressed during this event are solely those of Munevar & Associates, Inc., or the speakers, and do not represent the views of Harvard Catalyst, HCLITT, HCCL, Harvard University and its affiliated academic health care centers, the National Center for Research Resources, or the National Institutes of Health.